# NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
> **ANDA219334** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2026-08-04
## Drug
- **FDA Application Number:** ANDA219334
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
- **Generic name:** Nicardipine Hydrochloride
- **Active ingredients:** NICARDIPINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **First approval:** 2026-08-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219334)
---
*MORVS · CC0 1.0*